# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-009855
Filing Date
2020-04-22
Accepted
2020-04-22 17:30:35
Documents
19
Period of Report
2020-04-22

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | REPORT OF FOREIGN PRIVATE ISSUER | ea120972-6k_therapixbio.htm | 6-K | 11683
2 | PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON APRIL 22, 2020, TITLED THER | ea120972ex99-1_therapixbio.htm | EX-99.1 | 7784
3 | CORPORATE PRESENTATION OF THERAPIX BIOSCIENCES LTD., DATED APRIL 2020 | ea120972ex99-2_therapixbio.htm | EX-99.2 | 17998
4 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 8099
5 | GRAPHIC | ex99-2_001.jpg | GRAPHIC | 342329
6 | GRAPHIC | ex99-2_002.jpg | GRAPHIC | 635219
7 | GRAPHIC | ex99-2_003.jpg | GRAPHIC | 303111
8 | GRAPHIC | ex99-2_004.jpg | GRAPHIC | 434639
9 | GRAPHIC | ex99-2_005.jpg | GRAPHIC | 278884
10 | GRAPHIC | ex99-2_006.jpg | GRAPHIC | 380125
11 | GRAPHIC | ex99-2_007.jpg | GRAPHIC | 197626
12 | GRAPHIC | ex99-2_008.jpg | GRAPHIC | 420274
13 | GRAPHIC | ex99-2_009.jpg | GRAPHIC | 368810
14 | GRAPHIC | ex99-2_010.jpg | GRAPHIC | 313670
15 | GRAPHIC | ex99-2_011.jpg | GRAPHIC | 361280
16 | GRAPHIC | ex99-2_012.jpg | GRAPHIC | 254033
17 | GRAPHIC | ex99-2_013.jpg | GRAPHIC | 165415
18 | GRAPHIC | ex99-2_014.jpg | GRAPHIC | 594637
19 | GRAPHIC | ex99-2_015.jpg | GRAPHIC | 402762
| Complete submission text file | 0001213900-20-009855.txt |  | 7557437

Mailing Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047
Business Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 20808680
SIC: 2834 Pharmaceutical Preparations